Assembly Biosciences (ASMB) Receivables (2017 - 2026)
Assembly Biosciences' (ASMB) quarterly Receivables came in at $451000.0 in Q1 2026, down 53.7% quarter-over-quarter from $974000.0 in Q4 2025.
Assembly Biosciences (ASMB) Receivables (2017 - 2026) Analysis & Trends
Assembly Biosciences' Receivables history runs 10 years deep, the most recent figure standing at $451000.0 for Q1 2026.
- On a quarterly basis, Receivables changed N/A year-over-year to $451000.0 in Q1 2026; TTM through Mar 2026 was $451000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $974000.0, changed N/A from the prior year.
- Receivables slipped to $451000.0 in Q1 2026 per ASMB's latest filing, from $974000.0 in the prior quarter.
- Across five years, Receivables topped out at $1.2 million in Q3 2022 and bottomed at $43000.0 in Q4 2023.
- The 5-year median for Receivables is $524000.0 (2022), against an average of $610818.2.
- Across the five-year window, Receivables soared 180.95% in 2022 and plunged 95.44% in 2023, its largest moves.
- Year by year, Receivables stood at $944000.0 in 2022, then plunged by 95.44% to $43000.0 in 2023, then changed by 0.0% to $43000.0 in 2024, then soared by 2165.12% to $974000.0 in 2025, then slumped by 53.7% to $451000.0 in 2026.
- Per Business Quant, the three latest ASMB Receivables figures stand at $451000.0 (Q1 2026), $974000.0 (Q4 2025), and $912000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 4.97 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 938.02 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Assembly Biosciences | 431.63 Mn | 205.03 Mn | - | 451,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 451,000.00 |
| Dec 31, 2025 | 974,000.00 |
| Sep 30, 2025 | 912,000.00 |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Jun 30, 2023 | 342,000.00 |
| Mar 31, 2023 | 717,000.00 |
| Dec 31, 2022 | 944,000.00 |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 523,000.00 |
| Mar 31, 2022 | 524,000.00 |
| Dec 31, 2021 | 336,000.00 |
| Sep 30, 2021 | 769,000.00 |
| Jun 30, 2021 | 297,000.00 |
| Mar 31, 2021 | 203,000.00 |
| Dec 31, 2020 | 1.23 Mn |
| Sep 30, 2020 | 3.59 Mn |
| Jun 30, 2020 | 3.30 Mn |
| Mar 31, 2020 | 3.10 Mn |
| Dec 31, 2019 | 3.37 Mn |